Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil and EGb761 for Neurocognitive Function After Brain Radiation
NCT00070161Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jul 2001
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of donepezil and ginkgo biloba extract in acute radiation syndrome (ARS) (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Effect on neurocognitive function at 30 weeks. Started Jul 2001; status: completed.
02
Drugs
donepezilginkgo biloba extract
03
Conditions
acute radiation syndrome (ARS)
Beyond the preview
Go deeper on NCT00070161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070161.